| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9004945 | Biomedicine & Pharmacotherapy | 2005 | 4 Pages |
Abstract
Conclusion. - This gene expression profile is consistent with the involvement of SPARC in the mechanisms leading to the development of CsA-induced GO. By contrast, the undetectable SPARC mRNA levels in FK506-treated fibroblasts suggest that FK506 may be associated with a role of ECM stabilization, that does not induce GO.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Nicoletta Gagliano, Claudia Moscheni, Carlo Torri, Claudia Dellavia, Giordano Stabellini, Virgilio F. Ferrario, Magda Gioia,